M. Diviné

发表

A multicenter study of gemcitabine-containing regimen in relapsed or refractory Hodgkin's lymphoma patients

C. Fermé, C. Soussain, D. Decaudin, 2008, Anti-cancer drugs.

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.

J. Blay, B. Coiffier, H. Tilly, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Interleukin-2 treatment in lymphoma: a phase II multicenter study.

B. Coiffier, H. Tilly, C. Gisselbrecht, 1994, Blood.

Dexamethasone+Thalidomide (Dex/Thal) Compared to VAD as a Pre-Transplant Treatment in Newly Diagnosed Multiple Myeloma (MM): A Randomized Trial.

S. Chevret, M. Macro, V. Leblond, 2006 .

A Randomized Comparison of Dexamethasone + Thalidomide (Dex/Thal) vs Dex + Placebo (Dex/P) in Patients (pts) with Relapsing Multiple Myeloma (MM).

S. Chevret, X. Mariette, M. Macro, 2006 .

Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high-dose therapy.

C. Copie-Bergman, J. Jais, A. Rahmouni, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.

P. Ravaud, S. Chevret, X. Mariette, 1998, Blood.

Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety.

P. Lechat, G. Paintaud, M. Diviné, 2012, Therapie.

Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment.

P. Gaulard, A. Rahmouni, É. Lepage, 2001, Radiology.

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.

P. Feugier, S. Chevret, C. Chastang, 2001, Blood.

Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.

J. Raemaekers, A. Hagenbeek, G. Salles, 2007, The New England journal of medicine.

Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD). SFGM/GELA Study Group.

B. Coiffier, P. Rohrlich, É. Lepage, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Nodular, lymphocyte‐predominant Hodgkin lymphoma

B. Coiffier, A. Stamatoullas, V. Meignin, 2010, Cancer.

How to define intermediate stage in Hodgkin's lymphoma?

C. Gisselbrecht, C. Sebban, N. Mounier, 2005, European journal of haematology. Supplementum.

MRI and PET of bone marrow in lymphoproliferative diseases

A. Luciani, A. Rahmouni, C. Haioun, 2003, Cancer Imaging.

Lymphoma: imaging in the evaluation of residual masses

A. Rahmouni, H. Kobeiter, M. Anglade, 2002, Cancer Imaging.

Pathologic and Clinical Features of 77 Hodgkin's Lymphoma Patients Treated in a Lymphoma Protocol (LNH87): A GELA Study

P. Gaulard, F. Berger, J. Diebold, 2001, The American journal of surgical pathology.

MR appearance of multiple myeloma of the spine before and after treatment.

A. Rahmouni, C. Haioun, F. Reyes, 1993, AJR. American journal of roentgenology.

Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de Moëlle.

R. Bouabdallah, A. Baruchel, P. Moreau, 1997, Bone marrow transplantation.

Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry

R. Bouabdallah, A. Baruchel, P. Moreau, 1997, Bone Marrow Transplantation.

peculiar phenotype and with Epstein-Barr virus Nasal T-cell lymphoma: a clinicopathologic entity associated with

J. Bosq, F. Reyes, J. Brière, 2011 .

Lymphoma : A Clinicopathologic Entity Associated With Peculiar Phenotype and With Epstein-Barr Virus

P. Gaulard, J. Bosq, F. Reyes, 2003 .

Primary plasma cell leukaemia: a report of 18 cases.

R. Bouabdallah, D. Olive, A. Delmer, 2001, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

Poor lymphocyte recovery following CD34‐selected autologous peripheral blood stem cell transplantation for non‐Hodgkin's lymphoma

F. Reyes, D. Boutolleau, H. Jouault, 1999, British journal of haematology.

Early intensive therapy with autologous stem cell transplantation in advanced Hodgkin’s disease: retrospective analysis of 158 cases from the French registry

R. Bouabdallah, O. Casasnovas, C. Gisselbrecht, 1998, Bone Marrow Transplantation.

Expression of the Alpha/Beta and Gamma/ Delta T-cell Receptors in 57 Cases of Peripheral T-cell Lymphomas Identification of a Subset of y/6 T-ceII Lymphomas

P. Gaulard, C. Haioun, J. P. Couédic, 2007 .

Elevated levels of interleukin-1 beta (IL-1 beta) and IL-6 in serum and increased production of IL-1 beta mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome.

P. Gaulard, L. Bélec, R. Gherardi, 1994, Blood.

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple Myeloma.

J. Bourhis, V. Leblond, G. Marit, 1995, Stem cells.

High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients.

P. Ravaud, S. Chevret, X. Mariette, 1993, Blood.

Polymerase chain reaction (PCR) amplification demonstrates the absence of human T-cell lymphotrophic virus (HTLV)-I specific pol sequences in peripheral T-cell lymphomas

P. Gaulard, C. Haioun, F. Reyes, 1990, Journal of Clinical Immunology.

Mediastinal Diffuse Large‐Cell Lymphoma with Sclerosis: A Condition with a Poor Prognosis

P. Gaulard, F. Roudot-thoraval, C. Haioun, 1989, American journal of clinical oncology.

Peripheral T‐cell lymphoma presenting as predominant liver disease: A report of three cases

P. Gaulard, C. Haioun, E. Zafrani, 1986, Hepatology.

High‐dose therapy and autologous blood stem cell transplantation in multiple myeloma: Preliminary results of a randomized trial involving 167 patients

P. Ravaud, S. Chevret, X. Mariette, 1995, Stem cells.

Comparison of genetic probe with immunophenotype analysis in lymphoproliferative disorders: a study of 87 cases.

P. Gaulard, C. Haioun, M. Goossens, 1988, Blood.

Four ABVD and Involved-Field Radiotherapy in Unfavorable Supradiaphragmatic Clinical Stages (CS) I-II Hodgkin’s Lymphoma (HL): Preliminary Results of the EORTC-GELA H9-U Trial.

A. Hagenbeek, R. Bouabdallah, F. Morschhauser, 2005 .

Presence of HTLV‐I proviral DNA in patients with adult T‐Cell leukemia/lymphoma in Taiwan

P. Gaulard, T. Henni, C. Haioun, 1988 .

Rituximab in Combination with CHOP Regimen in Angioimmunoblastic T-Cell Lymphoma (AITL). Preliminary Results in 9 Patients Treated in a Single Institution.

P. Gaulard, A. Rahmouni, C. Haioun, 2005 .

Failure of 18Fluorodeoxyglucose Positron Emission Tomography to Detect the High-Grade Transformation of Nodular Lymphocyte Predominant Hodgkin’s Lymphoma

R. Perdrisot, F. Guilhot, M. Yacoub, 2013, Acta Haematologica.

Clinical and biological analysis of peripheral T-cell lymphomas: a single institution study.

P. Gaulard, F. Roudot-thoraval, C. Haioun, 1992, Leukemia & lymphoma.

Bone marrow histologic and immunohistochemical findings in peripheral. T-cell lymphoma: A study of 38 cases.

P. Gaulard, C. Haioun, F. Reyes, 1991, Human pathology.

Expression of the alpha beta and gamma delta T-cell receptors in peripheral T-cell lymphomas.

P. Gaulard, C. Haioun, F. Reyes, 1990, Nouvelle revue francaise d'hematologie.

ALK is not expressed in Hodgkin disease.

P. Gaulard, F. Berger, E. Macintyre, 2001, Blood.

Hairy cell leukemia associated with large granular lymphocyte leukemia: immunologic and genomic study, effect of interferon treatment.

P. Gaulard, F. Reyes, M. Tulliez, 1988, Blood.

Hairy Cell Leukemia Associated With Large Granular Lymphocyte Leukemia: Immunologic and Genomic Study, Effect of Interferon Treatment

P. Gaulard, F. Reyes, M. Tulliez, 1988 .

A subset of OKT4+ peripheral T cells can generate colonies containing mixed progeny with OKT4+ helper and OKT8+ suppressor cells

F. Reyes, N. Oudrhiri, J. Farcet, 1985, European journal of immunology.

Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell lymphoproliferative disorder.

P. Gaulard, C. Haioun, F. Reyes, 1988, Cancer.

Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging.

A. Rahmouni, F. Reyes, N. Vasile, 1993, AJR. American journal of roentgenology.

Human mononuclear phagocyte differentiation: a study of the U‐937 cell line by ultrastructural cytochemistry and surface antigen analysis

F. Reyes, A. Tabilio, M. Diviné, 1985, British journal of haematology.

Phenotype study of fresh and cultured hairy cells with the use of immunologic markers and electron microscopy.

F. Reyes, A. Tabilio, H. Jouault, 1984, Blood.

Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.

B. Coiffier, H. Tilly, É. Lepage, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CD3‐T cell receptor modulation is selectively induced in CD8 but not CD4 lymphocytes cultured in agar

P. Gaulard, F. Reyes, N. Oudrhiri, 1990, Clinical and experimental immunology.

Advanced hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy

F. Berger, É. Lepage, P. Brice, 2001, Cancer.

High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia

P. Feugier, S. Leprêtre, B. Grosbois, 2008, British journal of haematology.

Recombinative events of the T cell antigen receptor delta gene in peripheral T cell lymphomas.

P. Gaulard, M. Lefranc, C. Haioun, 1991, The Journal of clinical investigation.

Vasculitis in hairy-cell leukemia.

F. Reyes, M. Diviné, J. Farcet, 1987, Archives of internal medicine.

lymphoproliferative disorders: a study of 87 cases Comparison of genetic probe with immunophenotype analysis in

P. Gaulard, C. Haioun, M. Goossens, 2011 .

Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.

J. Bourhis, V. Leblond, G. Marit, 1995, Bone marrow transplantation.

Normal spinal bone marrow in adults: dynamic gadolinium-enhanced MR imaging.

A. Rahmouni, S. Breil, É. Lepage, 2003, Radiology.

Peripheral neuropathy, coagulopathy and nodular regenerative hyperplasia of the liver in a patient with multiple serologic auto‐antibody activities and IgM B‐cell lymphoma

P. Gaulard, E. Zafrani, G. Defer, 1989, Journal of internal medicine.

Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphomas. Identification of a subset of gamma/delta T-cell lymphomas.

P. Gaulard, C. Haioun, F. Reyes, 1990, The American journal of pathology.

Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta.

P. Gaulard, C. Haioun, M. Goossens, 1990, Blood.

P. Gaulard, L. Bélec, R. Gherardi, 1994, Blood.

Mechanism of accessory cell requirement in inducing IL 2 responsiveness by human T4 lymphocytes that generate colonies under PHA stimulation.

F. Reyes, D. Fradelizi, N. Oudrhiri, 1985, Journal of immunology.

Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study

P. Gaulard, B. Coiffier, H. Tilly, 1996 .

Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.

P. Gaulard, J. Bosq, F. Reyes, 1993, Blood.

Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression.

P. Gaulard, C. Haioun, F. Reyes, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC.

S. Leprêtre, S. Chevret, F. Davi, 2011, Blood.

Prognosis of patients with advanced hodgkin's disease

F. Berger, É. Lepage, P. Lederlin, 1997, Cancer.

Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.

S. Koscielny, C. Sebban, J. Bosq, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Functional analysis of CD8 lymphocytes in long-term surviving patients after bone marrow transplantation

F. Reyes, J. Vernant, T. Henni, 1988, Journal of Clinical Immunology.

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.

G. Salles, F. Berger, A. Stamatoullas, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.

F. Berger, C. Sebban, É. Lepage, 2000, Blood.

Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patients

B. Coiffier, B. Grosbois, C. Sebban, 2003, Leukemia.

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe.

P. Ravaud, S. Chevret, X. Mariette, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia.

P. Feugier, S. Leprêtre, B. Grosbois, 2004, Blood.

lymphocytic leukemia treatment on peripheral blood stem cell mobilization in B-cell chronic Impact of frontline fludarabine and cyclophosphamide combined

S. Leprêtre, B. Grosbois, A. Delmer, 2013 .

A comparison of the sensitivity of flow cytometry and bone marrow biopsy in the detection of minimal residual disease in chronic lymphocytic leukemia.

K. Maloum, B. Cazin, C. Lesty, 2006, Haematologica.

Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation.

J. Farcet, C. Calvo, J. Vernant, 1986, Journal of immunology.

Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging.

P. Gaulard, A. Rahmouni, É. Lepage, 2003, Radiology.

Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: A report of the french registry on autologous transplantation in multiple myeloma

R. Bataille, J. Bourhis, X. Troussard, 1995, Blood.

Phenotypic and genotypic heterogeneity in large granular lymphocyte expansion.

D. Le Paslier, D. Cohen, G. Flandrin, 1987, Leukemia.

Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia

F. Roudot-thoraval, J. Farcet, M. Delfau-Larue, 2002, British journal of haematology.

Transplantation in Waldenstrom's macroglobulinemia--the French experience.

J. Perrier, R. Gressin, V. Leblond, 2003, Seminars in oncology.

Analysis of prognostic factors after the first relapse of Hodgkin's disease in 187 patients

É. Lepage, O. Reman, J. Gabarre, 1996, Cancer.

A weekly regimen with dose escalation of doxorubicin for patients with advanced Hodgkin's lymphoma: Results of a phase II study of the Groupe d'Études des Lymphomes de l'Adulte (GELA)

O. Casasnovas, N. Mounier, P. Lederlin, 2007, Leukemia & lymphoma.

Risk-adapted salvage treatment with single or tandem autologous stem-cell transplantation for first relapse/refractory Hodgkin's lymphoma: results of the prospective multicenter H96 trial by the GELA/SFGM study group.

G. Salles, R. Bouabdallah, J. Jais, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MAL Expression in Lymphoid Cells: Further Evidence for MAL as a Distinct Molecular Marker of Primary Mediastinal Large B-Cell Lymphomas

C. Copie-Bergman, P. Gaulard, P. Möller, 2002, Modern Pathology.

Plasma cytokine and soluble receptor signature predicts outcome of patients with classical Hodgkin's lymphoma: a study from the Groupe d'Etude des Lymphomes de l'Adulte.

J. Blay, G. Salles, A. Stamatoullas, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Groupe d'Etude des Lymphomes de l'Adulte (GELA) patients with advanced-stage Hodgkin lymphoma: a study by the Long-term results and competing risk analysis of the H89 trial in

O. Casasnovas, C. Gisselbrecht, N. Mounier, 2013 .

[In Process Citation].

S. Laporte, M. Diviné, D. Girault, 2016, The´rapie (Paris).

Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.

P. Gaulard, C. Gisselbrecht, É. Lepage, 2001, The hematology journal : the official journal of the European Haematology Association.

Translational research: precision medicine, personalized medicine, targeted therapies: marketing or science?

P. Froguel, P. Marquet, F. Barlesi, 2015, Therapie.

[Non epidermotropic T lymphoma preceded for several years by hypereosinophilic syndrome].

C. Bodemer, C. Haioun, M. Bagot, 1990, Annales de dermatologie et de venereologie.

Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

O. Casasnovas, C. Gisselbrecht, N. Mounier, 2006, Blood.

First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favorable or unfavorable early stage Hodgkin’s lymphoma (HL)

E. Noordijk, M. Henry-Amar, F. Morschhauser, 2005 .

Activation by PHA of CD8 lymphocytes into clonal colony forming cells. Role of interleukin-1.

F. Reyes, A. Shaw, D. Fradelizi, 1988, Journal of immunological methods.

Evaluation of the BAX system for detection of Listeria monocytogenes in foods: collaborative study.

D. Lester, S. Kremer, J. Hembree, 2004, Journal of AOAC International.

Alternating Chemotherapy Does Not Improve Results in Poor-prognosis Aggressive Lymphomas - Lnh87 Protocol Group-3 - a Gela Study

P. Gaulard, B. Coiffier, H. Tilly, 1993 .

Current clinical trials for the treatment of adult advanced‐stage Hodgkin's disease: GELA experiences

N. Mounier, M. Diviné, C. Fermé, 2002 .

Hemophagocytic syndrome as a presenting sign of transformation of smoldering to acute adult T‐cell leukemia/lymphoma: Efficacy of anti‐retroviral and interferon therapy

A. Aouba, O. Lambotte, A. Bazarbachi, 2004, American journal of hematology.